Login
$BDX
$194.77 -$1.62 (0.82%) Live

Company Executives

$BDX Management Team

Mr. Thomas Polen

Chairman of the Board

President

Chief Executive Officer

Age 52
Compensation $17.13M USD
Sex Male

Ms. Shana Neal

Chief People Officer

Executive Vice President

Age 60
Compensation $3.308M USD
Sex Female

Mr. Richard Byrd

Executive Vice President

President - Interventional Segment

Age 58
Compensation $3.399M USD
Sex Male

Mr. Michael Feld

Executive Vice President

President - Life Sciences

Age 45
Compensation $4.096M USD
Sex Male

Mr. Michael Garrison

Executive Vice President

President - Medical Segment

Age 57
Compensation $3.649M USD
Sex Male

Mr. Roland Goette

Executive Vice President

President - EMEA

Age 63
Compensation -
Sex Male

Mr. Antoine Ezell

Executive Vice President

President

North America

Chief Marketing Officer

Age 56
Compensation -
Sex Male

Mr. Pavan Mocherla

Executive Vice President

President - Greater Asia

Age 56
Compensation -
Sex Male

Mr. Vitor Roque

Interim Chief Financial Officer

Age 43
Compensation -
Sex Male

Mr. Bilal Muhsin

Executive Vice President

President - Connected Care Segment

Age 45
Compensation -
Sex Male

Mr. David Shan

Executive Vice President

Chief Integrated Supply Chain Officer

Age 55
Compensation -
Sex Male
Directors
14
serving now
Independent
13 of 14
stated in the proxy
Average tenure
7.3 years
from year joined
CEO also chairs the board
Yes
Thomas E. Polen
Director Age On board Independent Committees Other public boards 2025 pay Source
William M. Brown
63 2022
3 years
Independent
Compensation and Human Capital Corporate Governance and Nominating
3M Company $335,172
Carrie L. Byington
62 2021
4 years
Independent
Audit Quality and Regulatory
None stated $345,172
R. Andrew Eckert
64 2016
9 years
Independent
Compensation and Human Capital · Chair Audit
Maravai Lifesciences Holdings, Inc. $365,172
Claire M. Fraser
70 2006
19 years
Independent
Compensation and Human Capital Corporate Governance and Nominating
Seres Therapeutics, Inc. Not stated
Gregory J. Hayes
65 2025
0 years
Independent
Audit Compensation and Human Capital
Phillips 66 Company $223,454
Jeffrey W. Henderson
61 2018
7 years
Independent
Audit · Chair Compensation and Human Capital
Qualcomm, Inc., Halozyme Therapeutics, Inc. $360,172
Robert L. Huffines
60 2025
0 years
Independent
Audit Corporate Governance and Nominating
Insulet Corporation $0
Christopher Jones
70 2010
15 years
Independent
Audit Corporate Governance and Nominating · Chair
None stated $365,172
Thomas E. Polen
52 2020
5 years
Not independent None stated None stated Paid as CEO
Timothy M. Ring
68 2017
8 years
Independent
Audit Quality and Regulatory
Quest Diagnostics Incorporated $335,172
Bertram L. Scott
74 2002
23 years
Independent
Compensation and Human Capital Quality and Regulatory
Dollar Tree, Inc. $375,172
Joanne Waldstreicher
65 2023
2 years
Independent
Corporate Governance and Nominating Quality and Regulatory
Structure Therapeutics, Inc. $336,172
Jacqueline Wright
65 2025
0 years
Independent
Audit Compensation and Human Capital
None stated $0
Catherine M. Burzik
Not stated Not stated Independent None stated None stated $360,172

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Dec 18, 2025
Timothy Ring
a director who, with his wife Kathryn Gleason, established the Non-Profit that will invest as a limited partner in TEAMFund, LP II
$2 million
five-year period

BD's anticipated $2 million capital commitment to TEAMFund, LP II, a for-profit limited partnership being formed by a non-profit established by Timothy Ring and his wife, Kathryn Gleason; the Governance Committee approved the proposed investment.

With TEAMFund, LP II Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support